The role of echocardiography in cardiovascular diseases assessment during pregnancy
Authors:
J. Král
Authors place of work:
Univerzita Karlova v Praze, 1. lékařská fakulta, III. interní klinika VFN
Published in the journal:
Čas. Lék. čes. 2009; 148: 374-378
Category:
Review Article
Summary
Maternal heart disease complicates at least 1% of pregnancies and is one of the most important causes of maternal death. Echocardiographic examination provides valuable information about the size and function of cardiac chambers, valve morphology and function, hemodynamic consequences of various cardiac pathologies. It is particularly important during pregnancy when the complaints and physical signs may be misleading. Echocardiography is well suited to rapid diagnosis in pregnant women with known or suspected cardiac disorders. This review article deals with the contribution of echocardiography to precise diagnosis and management of cardiovascular diseases in pregnancy.
Key words:
pregnancy, echocardiography, cardiovascular diseases.
Zdroje
1. Pieper PG. Expected and unexpected cardiac problems during pregnancy. Neth Heart J 2008; 12: 403–405.
2. Rizvi SFH, Khan MA, Kundi A, et al. Current status of rheumatic heart diseases in rural Pakistan. Heart 2004; 90: 394–399.
3. Siu SC, Coleman JM, Sorensen S, et al. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 2002; 105: 2179–2184.
4. Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 2007; 49: 2303–2311.
5. James AH, Jamison MG, Biswas MS, et al. Acute myocardial infarction in pregnancy: a United States population-based study. Circulation 2006; 113: 1564–1571.
6. Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. J Am Coll Cardiol 2008; 52: 171–180.
7. Presbitero P, Contrafatto I. Pregnancy and the Heart. In: Dalla Volta S (ed), Cardiology. 2. ed. London: McGraw-Hill 1999: 795–798.
8. Král J. Kardiovaskulární onemocnění v těhotenství. In: Aschermann M. (ed), Kardiologie. 1. ed. Praha: Galén 2004: 1357–1368.
9. Oakley C, Child A, Iung B, Presbitero P, et al. Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology. Expert consensus dokument on management of cardiovascular diseases during pregnancy. Eur Heart J 2003; 24: 761–781.
10. Why Mothers Die 2000–2002. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. Royal College of Obstetricians and Gynaecologists; London: 2004.
11. Siu SC, Sermer M, Harrison DA, et al. Risk and predictors for pregnancy–related complications in women with heart disease. Circulation 1997; 96: 2789–2794.
12. Bernstein IM, Ziegler W, Badger GJ. Plasma volume expansion in early pregnancy. Obstet Gynecol 2001; 97: 669–672.
13. Silversides CK, Colman JM. Physiological changes in pregnancy. In: Oakley C, Warnes C (eds). Heart Disease in Pregnancy. 2. ed. London: Blackwell BMJ Books 2007: 7–16.
14. Nihoyannopoulos P. Cardiovascular examination in pregnancy and the approach to diagnosis of cardiac disorder. In: Oakley C, Warnes C (eds). Heart Disease in Pregnancy. 2. ed. London: Blackwell BMJ Books 2007: 18–28.
15. Lesniak-Sobelga A, Tracz W, Kostkiewicz M, et al. Clinical and echocardiographic assessment of pregnant women with valvular heart diseases – maternal and fetal outcome. Int J Cardiol 2004; 94: 15–23.
16. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). J Am Coll Cardiol 2006; 48: e1.
17. Bonow RO, Carabello BA, Chatterjee K, et al. Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease. Circulation 2008; 118: e523–e661.
18. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230.
19. Feed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral valve prolapse. N Engl J Med 1999; 341: 1–7.
20. Aviernos JF, Gersh BJ, Melton LJ, et al. Natural history of mitral valve prolapse in the community. Circulation 2002; 106: 1355–1361.
21. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echo 2003; 16: 777–802.
22. Iung B, Gohlke-Barwolf, Tornos P, et al. Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J 2002; 23: 1253–1266.
23. Arnoni RT, Arnoni AS, Bonini RC, et al. Risk factors associated with cardiac surgery during pregnancy. Ann Thorac Surg 2003; 76: 1605–1608.
24. Oakley C, Child A, Iung B, et al. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Hear J 2003; 24: 761–781.
25. Silversides CK, Colman JM, Sermer M, et al. Cardiac risk in pregnant women with rheumatic mitral stenosis. Curr Probl Cardiol 2007; 32: 419–494.
26. Vahanian A, Palacios IF. Pecutaneous approaches to valvular disease. Circulation 2004; 109: 1572–1579.
27. Khairy P, Ouyang DW, Fernandes SM, et al. Pregnancy outcomes in women with congenital heart disease. Circulation 2006; 113: 517–524.
28. Perloff JK. The Clinical Recognition of Congenital Heart Disease, 5. ed. Philadelphia: WB Saunders, 2003.
29. Popelová J. Vrozené srdeční vady v dospělosti. 1. ed. Praha: Grada Publishing 2003.
30. Morley CA, Limb BA. The risks of delay in diagnosis of breathlessness in pregnancy. BMJ 1995; 311: 183–184.
31. Meijboom LJ, Vos FD, Timmermans J, et al. Pregnancy and aortic growth in the Marfan syndrome; a prospective study. Eur Heart J 2005; 26: 914–920.
32. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(Suppl. 3): 627S–644S.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Pheochromocytoma: diagnosis and treatment
- Diagnostics and treatment of organic hyperinsulinism – experience in 105 cases
- Hypertensive crisis – the present view
- Electrocardiography of yesterday and today